Updated Date: Tue, 28 Feb 2023 00:00:00 EST

Company has raised $112m in order to develop therapies for central nervous system disorders

Company’s skin health product poised for vital European market launch following success in the UK

Hair analysis could be the key to understanding adolescent drug usage, as a new study uncovers almost double […]

For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to […]

Vaccines developed at the facility will cover a wide range of respiratory diseases

The therapy becomes the first pegylated enzyme for the treatment of adult patients with Fabry disease

Researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery […]

Treatment is a lung-specific stem cell therapy designed for hospitalised patients with respiratory infections

Extensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients